5.09
price down icon2.30%   -0.12
after-market After Hours: 3.43 -1.66 -32.61%
loading

Mimedx Group Inc Stock (MDXG) Forecast

The Mimedx Group Inc (MDXG) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $4.8632, representing a -4.46% decrease from the current price of $5.09. The highest analyst price target is $5.1371, and the lowest is $4.5892.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MDXG Price Target
Average 5.7005 (+11.99% Upside)
loading

Is Mimedx Group Inc (MDXG) A Buy Now?

Oscillators
Name Value Action
RSI(14) 32.60 Neutral
STOCH(9,6) 57.27 Neutral
STOCHRSI(14) 78.84 Neutral
MACD(12,26) -0.2852 Buy
ADX(14) 53.18 Sell
William %R -61.17 Neutral
CCI(14) -7.7166 Neutral
Buy: 1 Sell: 1 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
5.112
Sell
5.1655
Sell
MA20
5.2265
Sell
5.3455
Sell
MA50
6.1385
Sell
5.895
Sell
MA100
6.5791
Sell
6.3212
Sell
MA200
6.6705
Sell
6.7562
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, MDXG could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on MDXG, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 32.6 indicates that MDXG is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 57.27 indicates that MDXG is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 78.84 indicates that MDXG is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 53.18 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -7.7166 indicates that MDXG is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term MDXG price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Mimedx Group Inc financial reports and earnings history, Mimedx Group Inc (MDXG) stock could reach $6.5681 by 2030, $13.49 by 2040 and $13.02 by 2050. See the projected annual prices until 2050 of the Mimedx Group Inc stock below:

  • Mimedx Group Inc (MDXG) is expected to reach an average price of $9.644 in 2035, with a high prediction of $10.28 and a low estimate of $7.3517. This indicates an $89.47% rise from the last recorded price of $5.09.
  • Mimedx Group Inc (MDXG) stock is projected to chart a bullish course in 2040, with an average price target of $11.68, representing an $129.39% surge from its current level. The forecast ranges from a conservative $11.49 to a sky-high $13.49.
  • Our analysts predict Mimedx Group Inc (MDXG) to jump 157.42% by 2045, soaring from $12.43 to an average price of $13.10, potentially reaching $14.71. While $12.43 is the low estimate, the potential upside is significant.
  • Mimedx Group Inc (MDXG) stock is expected to climb by 2050, reaching an average of $12.17, a $139.07% jump from its current level. However, a wide range of estimates exists, with high and low targets of $13.02 and $12.10, respectively, highlighting the market's uncertainty.

Mimedx Group Inc Stock (MDXG) Year by Year Forecast

Mimedx Group Inc Stock (MDXG) Price Forecast for 2026

The predicted value for Mimedx Group Inc (MDXG) in 2026 is set at an average of $4.9199. Estimates vary from a peak of $6.143 to a trough of $3.6968, indicating an -3.34% surge from the present price of $5.09.
Month Average Low High Change from today's price
March, 2026 $4.6602 $4.5892 $5.1371 -8.44%
April, 2026 $5.1653 $4.5412 $5.6643 +1.48%
May, 2026 $4.6394 $4.4094 $5.3363 -8.85%
June, 2026 $4.1635 $3.9325 $4.7854 -18.20%
July, 2026 $4.2186 $3.8455 $4.4055 -17.12%
August, 2026 $4.5127 $4.1396 $4.7607 -11.34%
September, 2026 $4.0478 $3.6968 $4.6847 -20.48%
October, 2026 $4.9719 $4.0888 $5.1519 -2.32%
November, 2026 $6.006 $4.8829 $6.084 +18.00%
December, 2026 $4.9711 $4.7911 $6.143 -2.34%

Mimedx Group Inc Stock (MDXG) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Mimedx Group Inc (MDXG) is $7.4806, with a high forecast of $10.60 and a low forecast of $4.3642. This indicates an +46.97% increase from the last price of $5.09.
Month Average Low High Change from today's price
January, 2027 $4.5952 $4.3642 $5.0221 -9.72%
February, 2027 $7.4293 $4.5962 $7.7043 +45.96%
March, 2027 $7.0449 $6.7644 $7.6313 +38.41%
April, 2027 $7.8585 $6.8004 $8.0925 +54.39%
May, 2027 $9.3726 $7.6495 $9.4326 +84.14%
June, 2027 $8.7277 $8.4556 $9.9036 +71.47%
July, 2027 $8.8918 $8.6597 $9.5958 +74.69%
August, 2027 $7.3959 $7.2263 $9.2928 +45.30%
September, 2027 $8.381 $6.89 $8.446 +64.66%
October, 2027 $9.3351 $8.282 $9.5251 +83.40%
November, 2027 $9.1292 $8.9392 $10.60 +79.35%
December, 2027 $9.1043 $8.9988 $9.8695 +78.87%

Mimedx Group Inc Stock (MDXG) Price Forecast for 2028

In 2028, Mimedx Group Inc (MDXG) is projected to reach an average price of $11.19, with a high projection of $15.37 and a low estimate of $6.9977. This indicates an +119.76% rise from the last price of $5.09.
Month Average Low High Change from today's price
January, 2028 $9.4984 $8.9453 $10.38 +86.61%
February, 2028 $9.3825 $9.0514 $10.14 +84.33%
March, 2028 $7.6176 $6.9977 $9.4635 +49.66%
April, 2028 $8.892 $7.4686 $9.482 +74.70%
May, 2028 $11.86 $7.8402 $12.59 +133.05%
June, 2028 $11.07 $10.95 $12.81 +117.49%
July, 2028 $12.20 $10.31 $13.26 +139.66%
August, 2028 $12.47 $10.84 $13.75 +144.97%
September, 2028 $15.05 $11.33 $15.11 +195.62%
October, 2028 $12.28 $11.76 $15.20 +141.16%
November, 2028 $13.38 $11.06 $13.85 +162.78%
December, 2028 $14.75 $12.88 $15.37 +189.85%

Mimedx Group Inc Stock (MDXG) Price Forecast for 2029

The 2029 price forecast for Mimedx Group Inc Stock (MDXG) is $12.05 on average, with a high prediction of $18.37 and a low estimate of $5.7279. This represents an +136.68% increase from the previous price of $5.09.
Month Average Low High Change from today's price
January, 2029 $14.76 $12.47 $15.30 +190.06%
February, 2029 $17.13 $13.74 $17.37 +236.58%
March, 2029 $8.6302 $7.6782 $18.37 +69.55%
April, 2029 $9.1584 $8.0463 $9.2684 +79.93%
May, 2029 $10.13 $8.8125 $11.09 +98.99%
June, 2029 $9.3768 $8.9547 $10.35 +84.22%
July, 2029 $8.045 $8.015 $9.4688 +58.05%
August, 2029 $7.0152 $6.6411 $8.027 +37.82%
September, 2029 $7.4834 $6.5513 $7.7834 +47.02%
October, 2029 $7.1536 $6.7195 $7.9454 +40.54%
November, 2029 $6.6418 $6.6218 $7.5027 +30.49%
December, 2029 $6.06 $5.7279 $6.8559 +19.06%

Mimedx Group Inc Stock (MDXG) Price Forecast for 2030

Mimedx Group Inc Stock (MDXG) is expected to reach an average price of $6.1923 in 2030, with a high forecast of $7.4211 and a low forecast of $4.9636. This signifies an +21.66% surge from the last price of $5.09.
Month Average Low High Change from today's price
January, 2030 $5.8802 $5.5102 $6.5681 +15.52%
February, 2030 $5.9384 $5.8222 $6.6522 +16.67%
March, 2030 $6.4265 $5.7825 $6.4465 +26.26%
April, 2030 $6.0247 $5.9647 $6.9086 +18.36%
May, 2030 $5.3749 $5.1849 $6.1468 +5.60%
June, 2030 $5.5031 $5.1011 $5.6611 +8.12%
July, 2030 $5.6434 $5.2772 $6.0213 +10.87%
August, 2030 $5.4815 $5.4315 $5.9495 +7.69%
September, 2030 $5.9297 $4.9636 $6.1297 +16.50%
October, 2030 $6.9199 $5.8618 $7.3199 +35.95%
November, 2030 $6.9781 $6.1681 $7.4211 +37.09%
December, 2030 $5.9763 $5.6743 $7.0202 +17.41%
$44.80
price up icon 1.24%
$26.75
price down icon 0.19%
$100.75
price up icon 1.93%
$105.76
price down icon 3.31%
$146.17
price down icon 1.52%
biotechnology ONC
$346.42
price down icon 1.38%
Cap:     |  Volume (24h):